Table 5.
Variable | Male |
Female |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Unadjusted β | SE | p value | Adjusted β | SE | p value | Unadjusted β | SE | p value | Adjusted β | SE | p value | |
Age | –0.004 | 0.002 | 0.034 | NA | 0.001 | 0.001 | 0.193 | |||||
Disease duration, yr | 0.005 | 0.005 | 0.403 | NA | 0.001 | 0.002 | 0.673 | |||||
Anti-CCP | 0.022 | 0.059 | 0.713 | NA | –0.063 | 0.024 | 0.009 | |||||
Current steroid dose | 0.001 | 0.017 | 0.957 | NA | 0.015 | 0.008 | 0.051 | |||||
BMI | 0.003 | 0.007 | 0.696 | NA | 0.003 | 0.003 | 0.018 | |||||
Skeletal muscle mass | 0.005 | 0.005 | 0.348 | NA | 0.002 | 0.004 | 0.635 | |||||
Body fat mass | 0.001 | 0.004 | 0.715 | NA | 0.002 | 0.001 | 0.165 | |||||
Bodyfat/skeletal muscle ratio | 0.017 | 0.035 | 0.638 | NA | 0.077 | 0.030 | 0.012 | 0.073 | 0.037 | 0.046 | ||
HAQ | 0.149 | 0.078 | 0.062 | NA | 0.110 | 0.018 | < 0.001 | 0.082 | 0.210 | < 0.001 |
DAS28, disease activity score in 28 joints; DAS28-P, an index derived to measure the subjective component of DAS28; SE, standard error; NA, not applicable; CCP, citrullinated protein antibody; BMI, body mass index; HAQ, health assessment questionnaire.